SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?


To: g.w. barnard who wrote (12478)8/2/1998 2:18:00 PM
From: VLAD  Read Replies (1) | Respond to of 23519
 
gw,

Wilson is now going to prove that he is either a total loser as a CEO of a publicly held company or else he will prove to have learned that Vivus can't compete with Pfizer and he will negotiate a deal with a strong domestic partner or else sell the company at a price that is acceptable to current share holders. It doesn't really matter which one he does. IMO if he sells the company we will see a much higher price in a very short time span. If he cuts a decent deal for a strong domestic partner then we will probably see an even higher share price but over a much longer time period.

I think most shareholders would rather see a sale of the company and not be left waiting for Vivus to return to profitability because we do not trust Wilson's judgement and we do not want our hard earned dollars left to any more of Wilson's decisions.

IMO, if Wilson does what is best for shareholder sentiment he will sell the company at a price that most of us shareholders can live with (for me personally I would hope that Vivus would sell for no less than $16.00-$17.00/share and hopefully more). Now if Wilson feels that he will do what he thinks is best for his own financial gain then he probably will not want to sell the company. If he feels that he can turn things around and is in no hurry to see the stock price back up to respectable levels then he may just be interested in a domestic partnership. Don't forget that if he sells the company he will also be selling his 6 figure annual salary which may be a pill that is too tough for him to swallow.

I was told by Vivus that their view on the company was geared towards the long term and that once the international markets were fully opened they expected to become extremely profitable. I do believe this to be true but I don't feel like owning this stock for another 6 to 12 months--unless of course I was guaranteed a $25.00+ stock by that time frame.